This is a big moment for the patients we hope to serve with NTLA-2001 – and for all who can benefit from the promise of genomic medicine. Our CEO, John Leonard, reflects on this milestone: https://t.co/CQV9wzABGV #CRISPR https://t.co/QlMSNBwGNS